According to the latest report by IMARC Group, titled “Osteoarthritis Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global osteoarthritis therapeutics market reached a value of nearly US$ 8 Billion in 2020. Looking forward, IMARC Group expects the global market to continue its moderate growth during 2021-2026.
Osteoarthritis (OA) is a common chronic joint disease that affects the hips, small joints of fingers, knees, and lower back and neck. The disease is the result of progressive degeneration of the protective cartilage. Some common OA symptoms include pain, tenderness, grating sensation, swelling, stiffness, loss of flexibility, and bone spurs. According to the alleviation levels of these symptoms, various surgical procedures and medications are prescribed to patients. Other than this, supportive devices, physical therapies, and alternative medicines are also utilized to improve joint function and relieve pain.
The major factors driving the global osteoarthritis therapeutics market include the rising prevalence of obesity, sedentary lifestyles and unhealthy dietary patterns of consumers. Along with this, the rising geriatric population, which is more susceptible to osteoarthritis, is propelling the demand for improved medicines and therapeutics across the globe. Rising expenditure for improving the healthcare infrastructure and investments in research and development (R&D) activities for introducing novel biomarkers and diagnostics are supporting the market growth further.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a PDF sample for more detailed market insights: https://www.imarcgroup.com/osteoarthritis-therapeutics-market/requestsample
Osteoarthritis Therapeutics Market 2021-2026 Competitive Analysis and Segmentation:
The competitive landscape of the global osteoarthritis therapeutics market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
The report has segmented the osteoarthritis therapeutics market on the basis of anatomy type, drug type, route of administration, end user and region.
Breakup by Anatomy Type:
Breakup by Drug Type:
Breakup by Route of Administration:
Breakup by End User:
Breakup by Region:
Explore full report with table of contents: https://www.imarcgroup.com/osteoarthritis-therapeutics-market
Key highlights of the report:
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
Asthma Therapeutics Market Report: https://www.imarcgroup.com/asthma-therapeutics-market
Cystic Fibrosis Therapeutics Market Report: https://www.imarcgroup.com/cystic-fibrosis-therapeutics-market
Protein Therapeutics Market Report: https://www.imarcgroup.com/protein-therapeutics-market
Cardiac Resynchronization Therapy (CRT) Market Report: https://www.imarcgroup.com/cardiac-resynchronization-therapy-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.